706 related articles for article (PubMed ID: 17592264)
21. Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases.
Signorelli M; Caspani G; Bonazzi C; Chiappa V; Perego P; Mangioni C
BJOG; 2009 Jan; 116(1):114-8. PubMed ID: 19087082
[TBL] [Abstract][Full Text] [Related]
22. Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
Vereide AB; Kaino T; Sager G; Ørbo A;
Gynecol Oncol; 2005 Jun; 97(3):740-50. PubMed ID: 15885761
[TBL] [Abstract][Full Text] [Related]
23. Treatment of endometrial hyperplasia with levonorgestrel releasing intrauterine devices.
Perino A; Quartararo P; Catinella E; Genova G; Cittadini E
Acta Eur Fertil; 1987; 18(2):137-40. PubMed ID: 3115027
[TBL] [Abstract][Full Text] [Related]
24. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
Simpson AN; Feigenberg T; Clarke BA; Gien LT; Ismiil N; Laframboise S; Massey C; Ferguson SE
Gynecol Oncol; 2014 May; 133(2):229-33. PubMed ID: 24561246
[TBL] [Abstract][Full Text] [Related]
25. Fertility-Sparing Management Using Progestin for Young Women with Endometrial Cancer From a Population-Based Study.
Kim SR; van der Zanden C; Ikiz H; Kuzelijevic B; Havelock J; Kwon JS
J Obstet Gynaecol Can; 2018 Mar; 40(3):328-333. PubMed ID: 28986185
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices.
Reyes HD; Carlson MJ; Devor EJ; Zhang Y; Thiel KW; Samuelson MI; McDonald M; Yang S; Stephan JM; Savage EC; Dai D; Goodheart MJ; Leslie KK
Gynecol Oncol; 2016 Jan; 140(1):152-60. PubMed ID: 26524723
[TBL] [Abstract][Full Text] [Related]
27. Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma.
Kudesia R; Singer T; Caputo TA; Holcomb KM; Kligman I; Rosenwaks Z; Gupta D
Am J Obstet Gynecol; 2014 Mar; 210(3):255.e1-4. PubMed ID: 24211482
[TBL] [Abstract][Full Text] [Related]
28. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
Cao DY; Yu M; Yang JX; Shen K; Huang HF; Cheng NH; Sun ZY; Deng CY; Yu Q; He FF
Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors of regression and relapse of complex atypical hyperplasia and well-differentiated endometrioid carcinoma with conservative treatment.
Yang YF; Liao YY; Liu XL; Su SG; Li LZ; Peng NF
Gynecol Oncol; 2015 Dec; 139(3):419-23. PubMed ID: 26494424
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
Park H; Seok JM; Yoon BS; Seong SJ; Kim JY; Shim JY; Park CT
Arch Gynecol Obstet; 2012 Feb; 285(2):473-8. PubMed ID: 21706284
[TBL] [Abstract][Full Text] [Related]
31. Complex hyperplasia of the endometrium. Predictive value of curettage vs. hysterectomy specimens.
Lambert B; Muteganya D; Lepage Y; Boivin Y
J Reprod Med; 1994 Aug; 39(8):639-42. PubMed ID: 7996530
[TBL] [Abstract][Full Text] [Related]
32. Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments.
Norimatsu Y; Shimizu K; Kobayashi TK; Moriya T; Tsukayama C; Miyake Y; Ohno E
Cancer; 2006 Apr; 108(2):77-85. PubMed ID: 16463402
[TBL] [Abstract][Full Text] [Related]
33. Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics.
McKenney JK; Longacre TA
Adv Anat Pathol; 2009 Jan; 16(1):1-22. PubMed ID: 19098463
[TBL] [Abstract][Full Text] [Related]
34. Digital morphometry of cytologic aspirate endometrial samples.
Mahovlić V; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Rajhvajn S; Juric D; Projić IS; Ilić-Forko J; Babić D; Skrablin-Kucić S; Bozikov J
Coll Antropol; 2010 Mar; 34(1):45-51. PubMed ID: 20437635
[TBL] [Abstract][Full Text] [Related]
35. Comparison of dilatation & curettage and endometrial aspiration biopsy accuracy in patients treated with high-dose oral progestin plus levonorgestrel intrauterine system for early-stage endometrial cancer.
Kim MK; Seong SJ; Song T; Kim ML; Yoon BS; Jun HS; Lee GH; Lee YH
Gynecol Oncol; 2013 Sep; 130(3):470-3. PubMed ID: 23822890
[TBL] [Abstract][Full Text] [Related]
36. Endometrial hyperplasia treated by progestins.
Eichner E; Abellera M
Obstet Gynecol; 1971 Nov; 38(5):739-42. PubMed ID: 5114224
[TBL] [Abstract][Full Text] [Related]
37. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
[TBL] [Abstract][Full Text] [Related]
38. [Endometrial atypical complex hyperplasia with extensive squamous metaplasia: two cases].
Hannachi Sassi S; Dhouib R; Abbes I; Braham E; Mrad K; Driss M; Ben Hamida N; Ben Romdhane K
Ann Pathol; 2008 Jun; 28(3):233-6. PubMed ID: 18706369
[TBL] [Abstract][Full Text] [Related]
39. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40.
Randall TC; Kurman RJ
Obstet Gynecol; 1997 Sep; 90(3):434-40. PubMed ID: 9277658
[TBL] [Abstract][Full Text] [Related]
40. [Atypical hyperplasia and complex hyperplasia of endometrium in women of reproductive age].
Guo LN
Zhonghua Fu Chan Ke Za Zhi; 1993 Dec; 28(12):725-7, 760. PubMed ID: 8137643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
